Call for Abstract

4th International Conference on Lipid Science and Technology, will be organized around the theme “Incipient Encroachments in the Field of Lipidology”

Lipids 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Lipids 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Advancements in the statin therapies, Clinical Lipidology goals to deliver an opportunity for novel clinical conclusions, therapeutic impressions of optimal management approaches and interpretation on upcoming trends, counting mixture of approaches, as well as cutting edge translational investigation, and will provide the progressively time-constrained scientific community with an accessible and absolute source covering all features of lipids in health and ailment. Significant improvements in the field are conveyed and analyzed by international professionals, providing an authoritative, but manageable, forum for this progressively chief area of exploration.

 

  • Track 1-1Drug Therapy
  • Track 1-2Statin Therapy
  • Track 1-3Myotonic Dystrophy
  • Track 1-4Candidate Gene Mutation
  • Track 1-5Heart failure
  • Track 1-6Diabetes
  • Track 1-7Hypertriglyceridemia
  • Track 1-8Niacin and Heart disease
  • Track 1-9Apolipoproteins
  • Track 1-10Cardiovascular disease (CVD)

Lipoproteins can be produced endogenously in the liver with endogenous triglycerides and cholesterol in the hepatocytes, which are from chylomicron remnants. The LDL flows in the bloodstream and can be captivated by cells in the liver or peripheral tissues. The particles can fix to the target tissue with the LDL receptor with the engrossment of apolipoprotein B-100 which can then be engrossed by endocytosis, and the units hydrolyzed to discharge lipids such as cholesterol.

The total cost of reducing low-density lipoprotein includes the costs of physician services, lifestyle counseling, screening, case finding and monitoring, dietary and exercise modifications, medications, and treating side effects. The annual cost of statin drugs to reduce low-density lipoprotein cholesterol levels can range from $1,082 to $1,543 per year. The cost of follow-up or treatment-related appointments varies by type of provider, location, and practice setting. Although the cost of reducing low-density lipoprotein cholesterol levels can be high, it is much lower than the direct and indirect costs of cardiovascular disease research.

  • Track 2-1Glycerolipids
  • Track 2-2 Sphingolipids
  • Track 2-3Saccharolipids
  • Track 2-4 Lipoprotein
  • Track 2-5Metabolic disorder

Clinical drugs that connect with membrane lipids and that modify the composition and structure of cell membranes can transform the localization and/or activity of membrane proteins. In general, adjustments in membrane lipid structure are emulated in changes in membrane lipid activity. Several drugs used to fight against cancer, cardiovascular diseases and obesity and other pathologies, determine lipid structure in plasma membrane and they produce a concomitant alteration in the localization and activity of signaling proteins. The recent studies have resulted in identifying specific disease-provoking gene mutations and have led to improved clinical and laboratory treatments, prenatal diagnosis in lipid related diseases.

The Injectable Drug Delivery Market by Formulation (Liposomes,  Nanoparticles and Microspheres), Devices and Therapeutics [Diabetes and Oncology] - Global Forecasts to 2017, dissects and contemplates the real market drivers, restrictions, and chances in North America, Europe, Asia-Pacific, and Rest of the World. Worldwide injectable medication conveyance advancements market over the gauge time of 2012 to 2017. 

 

  • Track 3-1 Drug delivery
  • Track 3-2Nanoparticles
  • Track 3-3Liposomes
  • Track 3-4Biochemistry
  • Track 3-5Membrane-lipid therapy
  • Track 3-6Biodiesel Biogas Syngas Biorefinery
  • Track 3-7Peripheral artery disease
  • Track 3-8 Angiography
  • Track 3-9Antimicrobial activity

Latest technology is used in Lipidomics to recognize, measure, and comprehend the construction and utility of lipids in biological systems.

Techniques include: mass spectrometry, fluorescence spectroscopy, nuclear magnetic resonance, microfluidic devices and column chromatography.

Identifying the lipid construction by mass spectrometry is complex due to varied lipid species and lipid molecular traits. Using the same method for all lipid classes for extraction, chromatography and detection is difficult. Lipidomics research is quite challenging, exciting, and unique because of the complexity and specificity. Conflicting to genomics and proteomics, there is no evidence that can forecast the number of individual lipid molecules present in an organism. 

  • Track 4-1Biochemical metabolism
  • Track 4-2microfluidic devices
  • Track 4-3Proteomics
  • Track 4-4 genomics
  • Track 4-5nuclear magnetic resonance
  • Track 4-6 ESI MS
  • Track 4-7MALDI MS
  • Track 4-8 APCI MS
  • Track 4-9Lipidomic profiling
  • Track 4-10column chromatography

Interpretation of LD-linked proteins, for example, oleosins, caleosins, and sterol dehydrogenases (steroleosins), has uncovered astonishing components of LD capacity in plants, including cell stress reactions, hormone flagging pathways, and different parts of plant development and improvement. Proteins like oleosin and caleosin are definite to plants, LD-related sterol dehydrogenases similarly are presented in well evolved creatures, and in both plants and warm blooded animals these compounds have been performed to be imperative in (steroid) hormone digestion system and flagging. Few proteins which are not vital in LD biogenesis in yeasts and vertebrates are conserved in plants, endorsing that in any event a few parts of LD biogenesis and/or capacity are developmentally monitored.

Lipids are stored in the form of triglycerides in plants. For examples higher plants. Plants like desert shrub, jojoba that stores lipid as a liquid wax. Lipids storage may be confined to seed tissue, embryo or endosperm whereas in oilseeds like sunflower, linseed or rapeseed, the cotyledons of the embryo are the major sites of lipid gathering. Species such as castor bean, coriander or carrot, the endosperm is the chief spot of lipid storage.

  • Track 5-1 Tocopherols
  • Track 5-2 Steroid
  • Track 5-3Cell stress
  • Track 5-4 Plant immunity
  • Track 5-5Plant adaptation and evolution
  • Track 5-6Plant synthetic biology
  • Track 5-7 Thylakoid
  • Track 5-8 Galactolipids
  • Track 5-9Phospholipids
  • Track 5-10 Hormone

Terpenes are the components of essential oils, which diverge from fatty oils as they do not have glycerides of fatty acids. Several essential oils comprise saturated and unsaturated aliphatic, aromatic, terpene, sesquiterpene, mono and bicyclic hydrocarbons, and the oxygen derivatives like aldehydes, alcohols, esters, ketones, lactones, ethers of acids, and oxides also heterocyclic compounds.

Lipids, lipophilic constituents and essential oils are extensively used in the food industry, engineering, pharmacy, perfumery and cosmetics, for the manufacture of lacquers and colours. Essential oils are situated in the flowers and leaves of plants and citrus fruits. Further in plants, lipids are most frequently concentrated in the seeds and fruits.

Terpenes are the components of essential oils, which diverge from fatty oils as they do not have glycerides of fatty acids. Several essential oils comprise saturated and unsaturated aliphatic, aromatic, terpene, sesquiterpene, mono and bicyclic hydrocarbons, and the oxygen derivatives like aldehydes, alcohols, esters, ketones, lactones, ethers of acids, and oxides also heterocyclic compounds.

 

  • Track 6-1Detoxification
  • Track 6-2Lipid peroxidation
  • Track 6-3Repellant and insecticidal activity
  • Track 6-4Cytotoxicity
  • Track 6-5Cancer chemoprotective activity
  • Track 6-6Anti-inflammatory activity
  • Track 6-7 Antifungal activity
  • Track 6-8Antioxidant activity
  • Track 6-9 Antibacterial activity

The role of oxidized lipids in cardiovascular diseases (CVD) has been investigated over the last three decades extensively. A number of studies have been carried out on the mechanisms, and pathways leading to the arterial atherosclerosis.

Atherosclerosis is the leading cause of death in North America and within the next two decades will be the leading cause worldwide. Atherosclerosis is characterized by vascular obstruction from the deposits of plaque, resulting in reduced blood flow. Plaque rupture and the consequent thrombosis may lead to sudden blockage of the arteries and cause heart attack. High serum lipid levels, especially the elevated level of low-density lipoproteins (LDL), have been shown to be strongly related to the development of atherosclerosis. It is generally accepted that atherosclerotic lesions are initiated via an enhancement of LDL uptake by monocytes and macrophages. In the liver, uptake of plasma LDL is mediated via specific LDL receptors, but a scavenger receptor system is employed by macrophages. Plasma LDL must be modified prior to uptake by macrophages.

 

  • Track 7-1 Cerebrovascular disease
  • Track 7-2 Ischemia
  • Track 7-3Elevated levels of LDL cholesterol and apolipoprotein B (apoB)
  • Track 7-4Familial hypercholesterolaemia (FH)
  • Track 7-5Computed tomography scan
  • Track 7-6Echocardiography
  • Track 7-7Coronary microvascular disease (MVD)
  • Track 7-8Hardening of the arteries
  • Track 7-9Arteriosclerosis
  • Track 7-10 Carotid artery disease
  • Track 7-11Coronary heart disease (CHD)
  • Track 7-12Angioplasty
  • Track 7-13Transient ischemic attacks (TIAs)
  • Track 7-14 Ischemia

Lipids are a different and ubiquitous cluster of compounds having key biological functions like structural constituents of cell membranes, aiding as energy storage bases and play a part in cell signaling pathways. Compound research in structural diversity of lipids benefits developments in the field of membrane lipids which in turn explains biological phenomena at the nanoscale sphere. 

Multiple roles can be performed by Phospholipids in cells by creating the permeability blockade for cells and cell organelles and by providing the matrix for the association and utility of a wide diversity of catalytic developments, also by substitute as donors in the production of macromolecules, and by keenly inducing the functional properties of membrane-associated developments.

  • Track 8-1Saturated fatty acid
  • Track 8-2Unsaturated fatty acid
  • Track 8-3Essential fatty acids
  • Track 8-4Cell signaling pathways
  • Track 8-5Fluid mosaic model

There are varied methodologies as biological tissues are not alike when considering their structure, texture, sensitivities and lipid contents. The ideology behind the solvent extraction is to completely extract all the lipid components from a sample, leaving the other components behind which always depends on the polarity of the lipids present. 

These techniques like classical Bligh & Dyer lipid extraction, chemical extractions by means of diverse solvents and sonication, direct saponification and supercritical CO2 extraction used to extract cellular or liquefied lipids from the other components like proteins, polysaccharides, small molecules (amino acids, sugars...) and use them for advanced investigations.

  • Track 9-1Polar lipids
  • Track 9-2 Electrophoresis (SDS-PAGE, IEF, non-denaturing electrophoresis)
  • Track 9-3Immunoassays
  • Track 9-4 Thin-Layer Chromatography (TLC)
  • Track 9-5 High Pressure Liquid Chromatography (HPLC)
  • Track 9-6Gas Chromatography
  • Track 9-7 Proteins
  • Track 9-8 Polysaccharides
  • Track 9-9 Amino acids
  • Track 9-10Chromatography

The economic burden of lipid disorders is substantial because of the impact of lipid levels on the risk of cardiovascular disease and coronary heart disease events. The direct and indirect costs of all types of cardiovascular disease in 2015 were estimated to be $706.2 billion. The cost of cardiovascular disease exceeds that of any other high-cost medical conditions. For example, in 2008, the estimated total cost of all cancers was $228 billion and in 2007, the cost attributable to diabetes mellitus was $174 billion.

The monetary load of lipid condition is considerable due to the impact of lipid altitudes on the risk of cardiovascular disease and coronary heart disease trials. The nature of fat is for the most part indicated by the relative substance of SFA, monounsaturated (MUFA), and polyunsaturated unsaturated fats (PUFA) including the extent or measure of vital unsaturated fats, that is, linoleic corrosive (LA) and α-linolenic corrosive (ALA), as well as the extent or measure of long-chain n-3 unsaturated fats (n-3 LCPUFA), that is, eicosapentaenoic corrosive (EPA) and docosahexaenoic corrosive (DHA). Coronary illness is perceived to be the reason for death for 80% of individuals with diabetes

  • Track 10-1Coronary Heart Disease
  • Track 10-2 Dietary fat
  • Track 10-3 Cardiovascular disease (CVD)
  • Track 10-4Insulin resistance
  • Track 10-5Thrombosis
  • Track 10-6Atherosclerosis
  • Track 10-7 Arrhythmias
  • Track 10-8 Hypertension
  • Track 10-9Heart failure

The biochemistry and sources of lipid compounds, followed by coverage of lipid requirements for a healthy state. Organized by lipid category, the text describes the role played by each lipid in various chronic diseases. It examines specific macronutrients and micronutrients, emphasizing their absorption, metabolism, and deficiency symptoms with respect to their roles in cardiovascular disease, cancer, metabolic diseases, inflammatory diseases, and various pathologies of the nervous system.

Lipids play a vital role in nutrition science, lead to new concepts with novel discoveries. Present track analyses the part of dietary lipids in sustaining health, fetching the up-to-date awareness from a countless of bases into one useful means. The joint methodology which incorporates lipid nutrition with standard physiology and clinical presentations.

  • Track 11-1Essential fatty acids
  • Track 11-2 Omega 3
  • Track 11-3 Cholesterol
  • Track 11-4 Polyunsaturated fatty acids (PUFA)
  • Track 11-5Cell membrane
  • Track 11-6 Biomarkers

Fossil fuels are the lifeblood of our society and for many others around the world. The environmental pollution due to the use of fossil fuels as well as their gradual depletion make it necessary to find alternative energy and chemical sources that are environmentally friendly and renewable.

Advancements in science and technology transforms biomass, as well as wastes, into Bioenergy comprising fuels, and fuel additives. Lipid hydrolysis is generally faster than protein or carbohydrate hydrolysis, and considered to be a rapid process in anaerobic digestion.

  • Track 12-1Microalgae
  • Track 12-2Anaerobic bioconversion
  • Track 12-3Enzymes
  • Track 12-4 Proteases
  • Track 12-5Lipases
  • Track 12-6Aerobic digestion
  • Track 12-7Algal biofuel
  • Track 12-8 Cellulases

Lipid rafts/caveolae flagon designed constructions are opulent in proteins and furthermore lipids example: cholesterol and sphingolipids and have a rare volumes in signal transduction. They assume a part in disease cells advancement, endocytosis and the uptake of pathogenic microorganisms and certain infections. Ponders that have illustrated the part of lipid pontoons in flagging by means of bioreceptor tyrosine kinases and G protein-coupled receptors. The inositol phospholipids frame the basic premise for a mind boggling interchange of flagging reactions created, most regularly, by receptor actuation and bringing about changes in Ca +2 , protein kinase falls, and particle channel/exchanger movement. Phosphatidylinositol (PI) itself is a negligible phospholipid constituent of all eukaryote plasma films.

Understanding the mechanisms of intracellular trafficking and its interaction with other signaling molecules may lead to novel approaches in the treatment of a number of hematologic and other diseases. NIH has invested $127,980 in this specific area in 2015.

  • Track 13-1Sphingolipid second messengers
  • Track 13-2Second messengers from phosphatidylinositol
  • Track 13-3Activators of G-protein coupled receptors
  • Track 13-4Activators of nuclear receptors

Obesity is the consequence of many factors functioning together such as the choices you sort, your metabolism, environment and genes in your body. Currently 66% of grown-ups and about 33% of youngsters battle with overweight and obesity. If heftiness rates stay reliable, by 2030, 51 percent of the populace will be obese. Today there are 41 states with stoutness rates more than 25 percent, as indicated by the Trust for Europe’s Health.

By European Association for the Study of Obesity, 482,000 Europeans kick the bucket of tumor every year, around 33% of these growth passings are connected to overabundance body weight, poor sustenance and/or physical idleness. More than 75 percent of hypertension cases are specifically connected to stoutness. Roughly 66% of Europe grown-ups with sort 2 diabetes are overweight or have heftiness.

  • Track 14-1High blood pressure
  • Track 14-2Low quality of life
  • Track 14-3 Type 2 diabetes
  • Track 14-4 Stroke
  • Track 14-5Body mass index (BMI)
  • Track 14-6Metabolic syndrome
  • Track 14-7Diabetes
  • Track 14-8Radioimmunoassay

Lipid microarrays will give an incorporated learning base to the human lipidome. Exogenous fat is transported in chylomicrons from the digestive system to the liver. After passage in the circulatory system the chylomicrons are hydrolyzed by the endothelial-enslaved lipoprotein lipase. The chylomicron leftovers are quickly taken up into the liver by means of the LDL receptor and the LDL receptor-linked protein. Apolipoprotein E and lipoprotein lipase are the acknowledgment signals for these receptors. The liver uses the exogenous fat and can discharge surplus lipids by means of VLDL into the blood. The remaining VLDL leftovers can either be taken up into the liver or are hydrolyzed to LDL. Both these types of Hypercholesterolemia are the most successive and speak to significant danger elements for arteriosclerosis.

Single lipid element will stay in the annular shell round a protein for a momentary timeframe. Tying to the annular shell indicates generally minimal auxiliary specificity. And the annular lipid, there is proof for other lipid atoms bound between the transmembrane alpha-helices of the protein; these lipids are alluded to as non-annular lipids. Voltage-gated channels are key transducers of film potential changes into intracellular homeless people that start numerous physiological occasions. The conformational change mutilates the state of the channel proteins adequately such that the depression, or channel, opens to concede particle flood or efflux to happen over the layer, down its electrochemical angle. 

 

  • Track 15-1 Binding of lipids to intrinsic membrane proteins in the bilayer
  • Track 15-2Perturbations of the lipid bilayer due to the presence of lateral membrane proteins
  • Track 15-3Backbone and solid chain dynamics of membrane proteins
  • Track 15-4Binding of peripheral membrane proteins to the lipid bilayer
  • Track 15-5Transducers
  • Track 15-6Lipid micro arrays